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ABSTRACT Monoclonal antibodies were previously used
to identify two glycoproteins, called fasciclin I and II (70 and
95 kDa, respectively), which are expressed on different subsets
of axon fascicles in the grasshopper (Schistocerca americana)
embryo. Here the monoclonal antibodies were used to purify
these two membrane-associated glycoproteins for further char-
acterization. Fasciclin II appears to be an integral membrane
protein, whereas fasciclin I is an extrinsic membrane protein.
The amino acid sequences of the amino terminus and fragments
of both proteins were determined. Using synthetic oligonucle-
otide probes and antibody screening, we isolated genomic and
cDNA clones. Partial DNA sequences of these clones indicate
that they encode fasciclins I and II.
Previous studies gave rise to the labeled pathways hypoth-
esis, which predicts that axon fascicles in the embryonic
neuropil are differentially labeled by surface recognition mole-
cules used for growth cone guidance (e.g., see refs. 1-6). To
identify candidates for axonal recognition molecules, mono-
clonal antibodies (mAbs) were generated that recognize sur-
face antigens expressed on subsets of axon fascicles in both
grasshopper (Schistocerca americana) (7) and Drosophila (8)
embryos.
These mAbs were used to characterize three different
membrane-associated glycoproteins, called fasciclin I and II
in the grasshopper and fasciclin III in Drosophila, which have
several features in common. All three proteins (i) are ex-
pressed on different subsets of axon fascicles during devel-
opment, (ii) are regionally expressed on particular portions of
embryonic neurons where their axons fasciculate together,
(iii) are dynamically expressed duiing axon outgrowth, and
(iv) are expressed outside the developing nervous system at
other times and places.
To begin a molecular genetic analysis of the structure and
function of these proteins, the genes encoding all three have
been cloned. The cloning offasciclin III from Drosophila was
previously reported (8). In this paper, we report on the
further characterization of the fasciclin I and II glycoproteins
in the grasshopper, and on the isolation and partial charac-
terization of cDNA clones encoding both molecules.**
MATERIALS AND METHODS
Protein Purification. Fasciclin I and fasciclin II were
purified by using an affinity matrix based on staphylococcal
protein-A-Sepharose (Pharmacia) as described (7, 9). Prepar-
ative NaDodSO4/polyacrylamide gel electrophoresis (Na-
DodSO4/PAGE) and electroelution were performed accord-
ing to established procedures (10). Removal of excess Coo-
massie blue and NaDodSO4 prior to protein sequence anal-
ysis by ion-pair extraction was performed as described by
Konigsberg and Henderson (11). For determination of the
amino-terminal sequences of intact fasciclin I or cyanogen
bromide (CNBr) fragments of fasciclins I and II, electro-
eluted samples were sequenced on a gas-phase microse-
quencer (Applied Biosystems, Foster City, CA, model 470A)
with an on-line HPLC for analysis of the phenylthiohydan-
toins of the amino acids, using the manufacturer's standard
reagents and programs.
Biochemical Techniques. Treatment of glycoproteins with
trifluoromethanesulfonic acid was performed as described by
Edge et al. (12). Proteins to be cleaved with CNBr were first
lyophilized. The samples (1-2 nmol) were solubilized in 200
/.l of 75% (vol/vol) trifluoroacetic acid (Pierce) saturated
with CNBr. Cleavage was allowed to proceed for 20-24 hr in
the dark at room temperature under nitrogen. Trifluoroacetic
acid was removed with a stream of nitrogen and the samples
were lyophilized from 1 ml of water three times. The cleaved
proteins were subsequently subjected to preparative NaDod-
S04/PAGE and electroelution.
Membranes were prepared from adult grasshopper ner-
vous systems as previously described (7). Membrane pro-
teins were labeled with 1251 and lactoperoxidase (13). In some
experiments, the labeled membranes were treated with 50
mM triethylamine, pH 11.5, for 15 min at 40C, and the
membranes were collected by centrifugation at 12,000 x g
and washed once with the same buffer. The supernatants
were combined and subjected to centrifugation at 100,000 x
g for 30 min. The stripped membranes were solubilized in 10
mM triethanolamine, pH 8.2/0.15 M NaCl/1% Nonidet
P-40/1mM phenylmethanesulfonyl fluoride for 30 min at 0°C,
and insoluble residue was removed by centrifugation at
100,000 x g for 30 min. Both supernatant and solubilized
membranes were subjected to immunoprecipitation with
preformed antibody complexes as described (14). Analytical
NaDodSO4/PAGE was performed according to Laemmli
(15). Silver staining was performed as described by Morrissey
(16).
Construction of Grasshopper Genomic and cDNA Libraries.
The grasshopper genomic library was constructed by stan-
dard methods (17) from grasshopper DNA partially digested
with Mbo I and size-fractionated. The DNA was ligated into
BamHI-digested AJ1 (18) vector arms and packaged.
Abbreviation: mAb, monoclonal antibody.
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The grasshopper embryo cDNA libraries were made from
poly(A) + RNA from dissected 40-50% developed grasshop-
per embryos. RNA was purified by lysis in guanidine hydro-
chloride followed by centrifugation through a cesium chloride
cushion (19). Double-stranded cDNA was made by a modi-
fication of the protocol of Gubler and Hoffman (20). The
cDNA was methylated with EcoRI methylase, ligated to
EcoRI linkers, recut, and size-fractionated on an agarose gel.
cDNA larger than 1.8 kilobases (kb) (about 10-20% of the
total cDNA molecules) was eluted, ligated into dephosphoryl-
ated Agtl1 arms (21), and packaged by using a packaging
extract from nonrestricting (r-) Escherichia coli (Stratagene,
San Diego, CA). Use of this extract proved to be important,
as another aliquot of the same cDNA pool from which nine
fasciclin I clones were isolated produced no fasciclin I clones
when packaged with an r+ extract of equal efficiency. The
fasciclin I cDNA sequence was found to contain an Eco K
site.
Oligonucleotide Probes and Library Screens. Oligonucleo-
tide probes were synthesized on an Applied Biosystems
synthesizer and 5'-end-labeled with polynucleotide kinase.
Hybridizations with the 44-mer probe were done in 6 x SSC
(1 x SSC = 0.15 M NaCI/0.015 M sodium citrate, pH 7.0) at
42°C, followed by low-stringency 1 x SSC washes and a final
wash in 3 M tetramethylammonium chloride at 68°C (22). For
hybridization to the redundant 20-mer pool, plaques ampli-
fied in situ (23) were transferred to nylon membranes and
hybridized to probe at 10 juCi/ml (1 Ci = 37 GBq) in 3 M
tetramethylammonium chloride at 51°C. The filters were also
washed in 3 M tetramethylammonium chloride (final wash at
59-600C).
Expression cloning with rat antisera was done by standard
methods (8, 21).
Other Molecular Biology Techniques. Southern blotting,
subcloning, and other molecular biology techniques were
performed by standard methods (24). DNA sequencing was
performed on M13 and Bluescript (Stratagene) subclones by
the dideoxy method (25). Clones for sequencing were gen-
erated from larger clones by unidirectional deletion with
exonuclease III (26).
RESULTS
Biochemical Characterization of Fasciclin I and Fasciclin H.
Fasciclin I and fasciclin II were initially identified by using
mAbs (7). The 3B11 and 8C6 mAbs immunoprecipitate
membrane-associated proteins from both adult grasshopper
central nervous system (CNS) and 40-50%o developed grass-
hopper embryos of 70 and 95 kDa, respectively. Because
these two proteins are expressed on different subsets ofaxon
fascicles during development (Fig. 1), we call them fasciclin
I and fasciclin II. Kilogram quantities of solubilized grass-
hopper embryos were used to purify microgram quantities of
each protein by immunoaffinity chromatography (Fig. 2). The
purified protein was used for the generation ofantisera in rats
(Fig. 1), for further biochemical characterization (Fig. 2), or
for protein microsequencing (Fig. 4).
Both proteins are glycosylated, as indicated by three
different lines ofevidence. First, both are bound by the lectin
concanavalin A (not shown). Second, the apparent molecular
weight of both proteins, when analyzed by NaDodSO4/
PAGE, is significantly decreased by treatment with trifluo-
FIG. 1. Expression offasciclin I (A) and fasciclin 11(B) glycoproteins on specific subsets ofaxon pathways in the grasshopper embryo. Serum
antibodies against the two purified proteins recognize the same subsets of axon pathways as do the mAbs against the same proteins, indicating
that the proteins are indeed expressed on restricted subsets of axons. (Bar = 50 ,um.)
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romethanesulfonic acid (Fig. 2), which has been shown to
cleave both N- and 0-linked sugars (12). Third, both proteins
are immunoprecipitated by the antibody to horseradish
peroxidase (27) that recognizes a neural-specific carbohy-
drate epitope in insects (28). The anti-horseradish peroxidase
immunoprecipitates only about 10%o of each protein, indicat-
ing heterogeneity in the glycosylation of both.
Analysis of the relative mobilities of the native and degly-
cosylated forms of fasciclin I (Fig. 2A) indicates that the core
protein has a molecular mass of 64 kDa with 8 kDa of
carbohydrate. Similarly, fasciclin II consists of a polypeptide
of 87 kDa and an oligosaccharide component of 6 kDa [this
result has been confirmed by the use of a lower percentage
acrylamide gel, which allows greater resolution in the appro-
priate molecular mass range (data not shown)]. The polypep-
tide components of fasciclin I and fasciclin II do not seem to
be related at the level of their primary sequences. Not only
are their sizes different, but neither one of them is recognized
on immunoblots by the antisera against the other one (data
not shown). In addition, two-dimensional peptide maps
indicate no similarities in their tryptic fragments (data not
shown). Neither fasciclin I nor fasciclin II is covalently linked
to itself or to other proteins as indicated by comparison of
reduced and nonreduced gels (Fig. 28). Moreover, no addi-
tional proteins are isolated by the antibody affinity columns,
indicating that neither protein is tightly associated with other
subunits.
While fasciclins I and II are similar in many of their bio-
chemical characteristics, they differ in one respect. Whereas
fasciclin II behaves as an integral membrane protein, fasciclin
I appears to be an extrinsic membrane protein. Thus, when
homogenized adult CNS preparations are subjected to differ-
ential centrifugation, both glycoproteins are found to be asso-
ciated with the membrane and not with the soluble fraction.
Further, monoclonal and serum antibodies against both pro-
teins stain the outer surface of axon fascicles in living grass-
hopper embryos (7).
However, the two proteins behave quite differently when
membrane preparations are subjected to alkaline conditions.
As shown in Fig. 3 (compare lanes 3 and 4), fasciclin II is
refractory to extraction at pH 11.5. While in this experiment
the background in the area of fasciclin II in the supernatant
lane is high, subsequent immunoprecipitations have con-
firmed the absence of fasciclin II from the extracted super-
natant. Likewise, the protein species in lane 4 at 70 kDa is
also present in the control lane (not shown) and has not been
observed consistently in similar experiments. We interpret
0
FIG. 3. Fasciclin I behaves as an extrinsic membrane protein,
while fasciclin II exhibits characteristics of an integral membrane
protein. Membranes prepared by differential centrifugation were
labeled with "25I and lactoperoxidase and subsequently treated with
a triethylamine buffer, pH 11.5. The proteins that were released into
the supernatant by such treatment (lanes 2 and 4) or were retained
with the membranes (lanes 1 and 3) were subjected to immunoprecip-
itation using mAbs against fasciclin I (lanes 1 and 2) or fasciclin II
(lanes 3 and 4). The immunoprecipitates were analyzed on a 10%o
polyacrylamide gel under reducing conditions.
this to indicate that this species is not a proteolytic fragment
of fasciclin II that is released into the supernatant.
In contrast to the results with fasciclin II, approximately
70%o of fasciclin I is released from the membrane preparation
under identical conditions (Fig. 3, lanes 1 and 2). The
remaining 30% of fasciclin I that remains associated with the
membranes most likely represents material that is trapped in
membrane vesicles and is therefore not released by this
treatment. Alternatively, it is possible that a subpopulation of
fasciclin I molecules are inserted into the membrane by a
phosphatidylinositol or other lipid linkage, as has been ob-
served with a number ofother membrane-associated proteins
(29), and thus remain associated with the membrane fraction
after extraction. This explanation is possible, as the sequence
of fasciclin I indicates that the mRNA encodes a signal
sequence, but no transmembrane domain (K.Z., L.M., and
C.S.G., unpublished data). Thus a mechanism other than a
protein insertion through the membrane must be invoked to
account for the retention of a portion of fasciclin I with the
membranes.
Extraction at high pH typically differentiates extrinsic mem-
brane proteins, which are released into the soluble fraction,
from integral membrane proteins, which are retained in the
membrane fraction. Such a difference between fasciclin I and
fasciclin II may reflect a fundamental difference in their modes
of action, despite their similarities in expression and biochem-
ical characteristics. To best study the functional roles ofthe two
proteins, we chose to isolate the genes encoding both mole-
cules.
Protein Sequencing of Fasciclin I and Fasciclin II. The
strategy that we adopted to isolate the fasciclin I and fasciclin
II genes depended upon obtaining amino acid sequence data
from both proteins. Affinity-purified fasciclin I and fasciclin
II were further purified by preparative NaDodSO4/PAGE
and electroelution (10). These preparations were subse-
quently subjected to amino acid sequence analysis on a gas-
phase sequenator (30). In the case of fasciclin I, the amino-
terminal sequence was determined for 18 amino acids (Fig.
4A). However, fasciclin II was found to be blocked at its
amino terminus and thus refractory to sequence analysis. To
obtain sequence information from fasciclin II, and to gain
additional data from fasciclin I, both proteins were cleaved
with CNBr, and the resultant peptides were purified by
preparative NaDodSO4/PAGE and electroelution. One pep-
tide from each preparation was selected for microsequencing
(Fig. 4). Although the fasciclin II peptide gave a single amino
acid sequence, the fasciclin I peptide gave two different
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A
(i) NH2-Lys-Gly-Glu-Lys-Ser-Leu-Glu-Tyr-Lys-Ile-Arg-Asp-Asp-Pro-Asp-Leu-Ala-Gln-COOH
(ii)
(iii)
(iv)
TAT AA ATD CGG GAT GAGA C G XAG
G
C
AAG GGC GAG AAG TCC CTG GAG TAC AAG ATC CGC GAC GAC CCC GA
MAG GGC GAG AAG TCG CTC GAG TAC AAG ATA CGC GAC GAC CCG GAC CTC TCA CAG
(v) NH2-Lys-Gly-Glu-Lys-Ser-Leu-Glu-Tyr-Lys-Ile-Arg-Asp-Asp-Pro-Asp-Leu-Ser-Gln-COOH
HAlaTh Ser Lys Asn Phe Asn Val Val His Gln Pro Ala G1yG1 Ser Thr Val L Val Leu2 Arg Gly Glne Asn Pro Asp Ala Phe Gly Phe Leu Lys Glu Asn Asp Glu
(vii) NH2-Ser-Thr-Serg lyGln-Leu-Tyr-Asn-Pro-Asp-Ala-Phe-Gln-Phe-Leu-Asn-Gln-Ser-Glu-Asn-Leu-Asp-Leu-Gly-COOH
(viii) NH2-Ala-Asp-Arg-Lys-Asn-Leu-Tyr-Phe-Asn-Val-Val-His-Gly-Pro-Ala-Gly-Asn-Lys-Thr-Val-Thr-Val-Glu-Gly-COOH
B
(i) NH2-Met-Val-Glu-Phe-l~ys-Pro-Ser-Phe-Ala-Asp-Thr-Pro-Gln-Lys-COOH
(ii)
(iii)
ATG GTG GAG TTC AAG CCC TCC TTC GCC GAC ACC CCC CAG MG
ATG GTG GAG TTC AAA CCG TCG TTC GCA GAC ACC CCA CAG AAG
(iv) NH2-Met-Val-Glu-Phe-Lys-Pro-Ser-Phe-Ala-Asp-Thr-Pro-Gln-Lys-COOH
FIG. 4. Comparison of amino acid and nucleotide sequences confirms the identity of clones encoding fasciclin I and fasciclin II. (A) Peptide
and oligonucleotide sequences of fasciclin I. (i) Affinity-purified fasciclin I was subjected to amino acid sequence analysis, yielding the
amino-terminal 18 amino acids. (ii) A 20-mer specifying all possible codons was synthesized. (iii) A unique 44-mer that was based upon Drosophila
codon usage was also synthesized. (iv) The true nucleotide sequence derived from the clone encoding fasciclin I. (v) The amino acid sequence
corresponding to the nucleotide sequence in iv. Note the serine at position 17 was not identified in the protein sequence. (vi) Amino acid sequence
ofa mixed CNBr fragment derived from fasciclin I compared with the corresponding sequences (vii and viii) as determined from the cDNA clone.
(B) Comparison of peptide and oligonucleotide sequences of fasciclin II. (i) Amino acid sequence of a CNBr fragment derived from
immunoaffinity-purified fasciclin II. (ii) A unique 42-mer was synthesized on the basis of Drosophila codon usage. (iii) The true nucleotide
sequence as derived from the clone isolated with the oligonucleotide. (iv) The amino acid sequence corresponding to nucleotide sequence iii.
amino acids at most residues, indicating that the band excised
from the gel actually contained two different peptides that
comigrated. Thus, for synthesizing oligonucleotide probes,
we used the amino-terminal amino acid sequence from
fasciclin I and the fragment amino acid sequence from fasciclin
II.
Cloning and Partial Sequence of Fasciclin I and Fasciclin fl.
To isolate the fasciclin I gene, we designed oligonucleotide
probes based on the sequence of the 18 amino acids at its
amino terminus. Two types of probes were used: a unique
44-mer composed of the codons used most frequently in
Drosophila proteins, and a 288-fold redundant 20-mer probe
containing all possible codons (Fig. 4A).
We used the 44-mer probe to screen 750,000 plaques (2-3
genome equivalents) of an unamplified grasshopper genomic
library. Three strongly positive plaques were isolated, and
these were found to have a match of at least 18/20 with a
sequence within the 20-mer pool by determining the melting
temperature ofthe hybrids in tetramethylammonium chloride
(22). Hae III and Tha I fragments hybridizing to the 44-mer
were subcloned from the three phage and sequenced, and it
was found that two of the clones encoded the amino-terminal
sequence of fasciclin I. One amino acid was found to be
different from that determined by protein sequencing (the
serine at position 17); this residue was not within the region
used to design the probe. Subsequent analysis indicated that
the 18th amino acid is followed by an intervening sequence.
Because no other coding sequence was found in the genomic
clones, they were not studied further.
We next constructed several cDNA libraries from 40-50%o
developed grasshopper embryos and screened them with the
44-mer under conditions in which only authentic fasciclin I
clones would be able to hybridize. These conditions were
determined from the results of the genomic library screen.
cDNA clones containing the amino-terminal sequence that
hybridizes to the 44-mer would have to be nearly full-length
copies of fasciclin I mRNA. Subsequent analysis showed that
this mRNA is of very low abundance, consistent with the
result that hybridizing clones were found at a very low fre-
quency. Nine clones were eventually isolated from a screen of
600,000 plaques of an unamplified, 5- to 10-fold size-selected
Agtll library packaged by using extract from a nonrestricting E.
coli strain. A 3.2-kb clone was completely sequenced and found
to encode a 70-kDa protein whose amino-terminal sequence
was identical to that determined from the genomic DNA. This
clone also contained two sequences that together match the
peptide mixture sequence described above (Fig. 4). In addition,
one of the 44-mer-positive cDNA clones produced a fusion
protein that reacted with antiserum against fasciclin I. Thus, we
are confident that these clones actually encode this protein. The
complete sequence of fasciclin I will be described elsewhere.
Fasciclin II cDNA clones were isolated in a similar
manner. Since the fasciclin I sequence indicated that grass-
hopper codon usage was identical to that in Drosophila, we
used only a unique 42-mer probe based on the CNBr fragment
sequence described above. We screened 400,000 plaques
from the size-selected cDNA library with this probe, and
isolated eight clones, ranging in size from 3 to 4.5 kb. Hybrids
between each of these clones and the 42-mer melted at the
same temperature in tetramethylammonium chloride.
In addition, we screened 600,000 plaques of a different
Agtll cDNA library with the antiserum against fasciclin II,
and we isolated one antibody-positive 2-kb clone. This clone
was found to hybridize with the 42-mer under the same
conditions as the other clones. All of these oligonucleotide-
and antibody-positive clones cross-hybridize at high strin-
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FIG. 5. Southern blot analysis of genomic DNA encoding the
fasciclin I and II proteins. Twenty micrograms of grasshopper
genomic DNA was digested with EcoRI (lanes 1 and 3) or BamHI
(lanes 2 and 4) and the resultant fragments were separated on an
agarose gel. After transfer to GeneScreenPlus, hybridization was
performed with 32P-labeled cDNAs encoding fasciclin I (lanes 1 and
2) or fasciclin II (lanes 3 and 4).
gency. The sequence of the 2-kb clone indicated that it
encoded the fascicin II peptide (Fig. 4B). Since clones con-
taining this peptide sequence also are capable of reacting with
the antiserum, they are likely to encode part or all ofthe fasciclin
II protein.
Both genes appear to occur in a single copy per haploid
genome. As shown in Fig. 5, when grasshopper genomic
DNA blots are probed with the fasciclin I and fasciclin II
cDNA clones at high stringency, each hybridizes to a small
number ofbands, consistent with a single copy gene or a small
number of very closely related genes. The distinct patterns
obtained further emphasize that the two proteins are encoded
by different genes.
DISCUSSION
We began these studies with mAbs that recognize two
different surface glycoproteins, called fasciclin I and fasciclin
II, which are expressed on subsets of axon fascicles in the
grasshopper embryo (7). In this paper, the mAbs were used
to purify the proteins for further biochemical characterization
and microsequencing. This sequence information allowed us
to design oligonucleotide probes that we used to clone the
genes encoding fasciclin I and fasciclin II.
Fasciclin I and fasciclin II are unique membrane-associat-
ed glycoproteins of molecular mass 70 and 95 kDa, respec-
tively; neither protein appears to be covalently associated
with any other protein. Fasciclin II appears to be an integral
membrane protein, whereas fasciclin I appears to be an
extrinsic membrane protein. Both are glycosylated, and both
are among a large group of neuronal surface glycoproteins
that express the carbohydrate that cross-reacts with antibod-
ies to horseradish peroxidase (28).
The isolation of the genes encoding these two glycopro-
teins in the grasshopper is a first step toward understanding
their structure and function. Both are expressed on a subset
of axon fascicles during neuronal development in a manner
consistent with a role in cell recognition and growth cone
guidance. It will now be of interest to determine the structure
of these proteins and search for related proteins. To test the
function of these molecules, we would ultimately like to use
genetic analysis in Drosophila. Given the similarity in the
patterns of identified neurons, selective fasciculation, and
growth cone guidance between grasshopper and Drosophila
(3, 31), it should now be possible to use the DNA probes for
these genes from grasshopper to search for homologous
genes in Drosophila.
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